Expression of nm23-H1 in hydatidiform mole and its relationship with the development of postmolar disease.

The aim of the present study was to investigate the expression of nm23-H1 in human placenta, hydatidiform mole and choriocarcinoma cells. Nm23-H1 protein was localized in the cytotrophoblast, but not in the syncytiotrophoblast. In the hydatidiform mole cases with subsequent spontaneous remission, nm23-H1 mRNA levels were significantly lower than those in first-trimester placentas. However, its levels were elevated in the hydatidiform mole cases that progressed to persistent gestational trophoblastic disease and were comparable to those of first-trimester placentas, and they were further elevated in choriocarcinoma cells. The present data suggest an association of nm23-H1 for the proliferation activity of trophoblast, and its increased expression may influence the development of persistent trophoblastic disease.
AuthorsK Iwase, T Okamoto, R Nui, S Mizutani
JournalGynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 51 Issue 4 Pg. 228-32 ( 2001) ISSN: 0378-7346 [Print] Switzerland
PMID11408732 (Publication Type: Journal Article)
CopyrightCopyright 2001 S. Karger AG, Basel
Chemical References
  • NM23 Nucleoside Diphosphate Kinases
  • RNA, Messenger
  • Transcription Factors
  • NME1 protein, human
  • Nucleoside-Diphosphate Kinase
  • Monomeric GTP-Binding Proteins
  • Blotting, Northern
  • Choriocarcinoma (chemistry)
  • Female
  • Gestational Age
  • Humans
  • Hydatidiform Mole (chemistry, complications)
  • Immunohistochemistry
  • Monomeric GTP-Binding Proteins (analysis, genetics)
  • NM23 Nucleoside Diphosphate Kinases
  • Nucleoside-Diphosphate Kinase
  • Placenta (chemistry)
  • Pregnancy
  • RNA, Messenger (analysis)
  • Transcription Factors (analysis, genetics)
  • Trophoblastic Neoplasms (chemistry, etiology)
  • Trophoblasts (chemistry)
  • Tumor Cells, Cultured
  • Uterine Neoplasms (chemistry, complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: